The German Research Foundation (DFG) will continue to fund the Transregional Collaborative Research Centre “SFB Transregio 19” “Inflammatory Cardiomyopathy – Molecular Pathogenesis and Therapy” for another four years with a total of 10 million euros. The Department of Cardiology of the University Hospital of Tübingen will also become part of the SFB.
The SFB deals with the investigation of the concrete causes of inflammatory cardiomyopathy on the cellular and molecular level. Prof. Dr. Reinhard Kandolf, Medical Director of the Department of Molecular Pathology at the Institute of Pathology in Tübingen comments: “We are hoping to characterise the virus-host interactions and are confident that we will be able to develop effective therapies. We are international leaders in the field of inflammatory cardiomyopathy, particularly in cardiopathological diagnostics, research into the causes of DCM and the development of new therapeutic strategies. That’s why the German Research Foundation granted us the SFB, a collaborative research project bringing together the Department of Cardiology as well as theoretical disciplines from the Institute of Physiology (Prof. Dr. Florian Lang), the Institute of Immunology (Prof. Dr. Hans-Georg Rammensee, Prof. Dr. Stephan Stevanovic).The “SFB Transregio 19” brings together university hospitals as well as university and non-university research institutions in Berlin, Greifswald and Tübingen.